Juvenile Absence Epilepsy — Clinical Trials

MONDO:08004533 active·2 recruitingLast updated: Mar 16, 2026, 4:24 AM

Trial Landscape

Juvenile Absence Epilepsy has an emerging clinical trial program, driven by drug treatment.

Recruiting

Active Trials

By Approach

Drug Treatment3

2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 3

Sponsor Types

Industry2Academic/Other1

Top Sponsors

UCB Biopharma SRL

Trial Locations

United States3 trials

Georgia2 trials

Italy2 trials

Romania2 trials

Slovakia2 trials

Spain2 trials

Ukraine2 trials

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 3Recruiting

NCT06315322

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Sponsor:UCB Biopharma SRL

United StatesStarted: Jul 2024Est. completion: Mar 2030Updated: Mar 2026

Phase 3Recruiting

NCT04274179

Ketogenic Diet for New-Onset Absence Epilepsy

Sponsor:Johns Hopkins University

United StatesStarted: Aug 2020Est. completion: May 2026Updated: Aug 2025

Phase 3Active, Not Recruiting

NCT04666610

A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Sponsor:UCB Biopharma SRL

United StatesStarted: Jul 2021Est. completion: Aug 2026Updated: Mar 2026

Stay informed about clinical trials for Juvenile Absence Epilepsy.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 16, 2026 at 4:24 AM